DOCTOR FUNGUS
CME program -
"The Practical Approach to Echinocandin Therapy"

Lectures from the symposium at Focus on Fungal Infections 14 - March 24-26, 2004 New Orleans, Louisiana		  
Faculty Disclosure

Thomas F. Patterson, MD, FACP
  • Bristol-Myers Squibb Company1.2
  • J. Uriach and Cia.S.A.2
  • Microbia Inc.2
  • Pfizer1.2.3
  • Schering-Plough Corporation1.2
  • Affinium Pharmaceuticals2
  • Basilea2
  • Vicuron2
  • 3M1
  • Pfizer1
1=Grant/research support | 2=Consultant
3=Speaker's bureau | 4=Stock shareholder
5=Other support


Jack D. Sobel, M.D.
  • 3M1
  • Pfizer1
1=Grant/research support | 2=Consultant
3=Speaker's bureau | 4=Stock shareholder
5=Other support

The following speakers have reported an affiliation with the supporter of this enduring material:

  • Thomas F. Patterson, MD, FACP
      grant/research support, consultant, speaker's bureau

  • Jack D. Sobel, M.D.
      grant/research support

  • Thomas J. Walsh, MD
      cooperative research & development agreement



    • Imedex, Inc. is an independent provider of Continuing Medical Education. Imedex, Inc. has no proprietary or financial interest in medical or healthcare products over which the FDA has regulatory authority.

    Close this window